Wordt geladen...
Adjuvant Endocrine Therapy in Early Postmenopausal Breast Cancer
Five years of adjuvant tamoxifen treatment has been the gold standard for women with early hormone-responsive breast cancer. Results from two large phase III, adjuvant studies have indicated that the third-generation aro-matase inhibitors (AIs) letrozole and anastrozole offer greater protection agai...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
S. Karger GmbH
2008
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2931103/ https://ncbi.nlm.nih.gov/pubmed/20824026 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000155548 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|